摘要 |
<p>The invention describes pan-specific monoclonal antibodies for the determination of the amount of all structural variants of glycated hemoglobin in human blood samples. The determination of the rate of glycation of hemoglobin in an individual's blood provides a useful index of glucose level control in diabetics.</p> |